Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Investigating High Resolution OCT, Multifocal ERG and Microperimetry Outcomes of Monthly vs As Needed Ranibizumab in Neovascular Age-Related Macular Degeneration

NCT00764738 is registered in ClinicalTrials.gov with Retina Macula Institute as lead sponsor.

NCT NCT00764738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00764738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Investigating High Resolution OCT, Multifocal ERG and Microperimetry Outcomes of Monthly vs As Needed Ranibizumab in Neovascular Age-Related Macular Degeneration
Lead sponsor
Retina Macula Institute
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2008
Completion date
November 30, 2011
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age related macular degeneration